Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
about
Effect of nadolol in treatment of hypertensionDiacetyl nadolol: 3-month ocular hypotensive effect in glaucomatous eyes.A study of nadolol to determine its effect on ambulatory blood pressure over 24 hours, and during exercise testingImproved physical performance as a therapeutic objective in patients with angina.Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.Elimination of nadolol by patients with renal impairment.Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aortaAgonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes.Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectorisFunctional beta3-adrenoceptor in the human heart.Metabolic studies in patients with nadolol: oral and intravenous administration.Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.Initial experience with a new long-acting beta-blocker, nadolol, in hypertensive patients.Angina pectoris: effective therapy once daily.Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system.Pharmacokinetics of nadolol, a beta-receptor antagonist: administration of therapeutic single- and multiple-dosage regimens to hypertensive patients.beta3-adrenoceptor control the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway.A response to isoprenaline unrelated to alpha- and beta-adrenoceptor agonism.Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.Concentration-effect relationships with FM 24: a new long acting beta-adrenergic receptor antagonist.Electrophysiological abnormalities and enhanced reperfusion arrhythmias in the isolated hearts of hyperthyroid rats.Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.Oral Nadolol for the Treatment of Infantile Hemangiomas: A Single-Institution Retrospective Cohort Study.
P2860
Q28317286-FB4197BA-F2EE-43D0-9734-A1246C3F0633Q33642844-6A364EFC-F469-4FD3-9C0B-D277CCBD30EBQ34511635-F966F462-DFFB-40B4-86AF-70C9F871E54DQ34516462-7E5A5C4B-980E-46B6-9E6F-2BFC049CEA74Q34516475-E70C0E78-8333-48EE-A61F-84AF2027369AQ34516483-044932C2-5D60-4888-9F44-F07BAEE0B5CEQ35041493-264C6DA5-6A14-41D6-8938-B56144764B8DQ35756011-7B9B60BF-7AD2-43AC-9900-BDBE5D8DE427Q36329658-0BC490E8-4056-442B-8BBF-3EE3546582E4Q36784618-8F21C2E6-08A1-450F-8FFB-BCE2ECDFC3D1Q37357935-ED6E9502-198C-4A58-BC4E-B57DDD110CCEQ39145133-258926E1-EFDB-437D-AC12-2057C9D058E3Q39231985-075D3F85-E682-4A33-A833-74314A78949FQ39238440-6ACCE7C2-E8D7-4581-854E-44E17989328BQ39238448-5D8BFC88-57C4-4A1F-9278-F653AAA73E92Q39261760-60EDB4CA-A4B3-47E7-9FF6-B00270866948Q39300419-DA664DFD-6FBD-45ED-8003-94039BA91E79Q40970969-883CD580-664A-4569-A842-97F0140C0B5FQ41344679-2DA811B5-F835-4CDB-B9E3-760C94086C55Q41819439-15462D79-5702-428F-8CBA-7634359ED087Q42069804-54D65177-9A74-408B-9E06-E8B665BB3F69Q42847673-65A19442-C492-405F-BBA6-9547C67AE284Q43195812-43DB2190-21D6-42B4-8ED7-2891D44569DCQ52994327-53E3A52C-FC39-4E8C-8AC5-C48CEC2A4D99
P2860
Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Pharmacology of nadolol (SQ 11 ...... direct myocardial depression.
@en
type
label
Pharmacology of nadolol (SQ 11 ...... direct myocardial depression.
@en
prefLabel
Pharmacology of nadolol (SQ 11 ...... direct myocardial depression.
@en
P2093
P1476
Pharmacology of nadolol (SQ 11 ...... direct myocardial depression.
@en
P2093
P304
P356
10.1016/0014-2999(75)90182-X
P407
P577
1975-09-01T00:00:00Z